Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viokase 16 for Steatorrhea in Exocrine Pancreatic Insufficiency
NCT00559364Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Nov 2007
- Primary completion
- Jul 2009
- Modality
- Replacement Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of Pancreaze in exocrine pancreatic insufficiency (EPI), sponsored by Forest Laboratories. Started Nov 2007; status: completed.
02
Drugs
Pancreaze
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT00559364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559364.